Innovating at the speed of AI
The world has undergone a rapid and transformative shift since the adoption of AI. This is particularly evident in biopharma, where the possibility of a truly ground-breaking solution that accelerates research, disease diagnosis and trial-matching is at hand.
We’ve assembled an exceptional team to do just that, comprised of individuals with an indisputable track record of excellence.
Our quest is backed by savvy investors who support our vision of GenAI applications for the Pharma sector.
Meet the team
Dr. Chadi Nabhan is the Chief Medical Officer and Head of Strategy at Ryght, bringing over 20 years of oncology and leadership experience to drive innovation and strategic vision.
His past roles include SVP and Chairman of the POA at Caris Life Sciences, VP and CMO at Cardinal Health Specialty Solutions, and EVP and CMO at Aptitude Health. Academically, he has served as an Associate Professor of Medicine and the Director of Outpatient Cancer Clinics at the University of Chicago, and before that, Chief of Oncology and Cancer Institute Medical Director at Advocate Lutheran General Hospital in Park Ridge, IL. Dr. Nabhan is an esteemed author, podcaster, and speaker, recognized for his contributions to medical oncology and clinical research.